Signal Transduction and Targeted Therapy (Sep 2022)
Pro-senescence neddylation inhibitor combined with a senescence activated β-galactosidase prodrug to selectively target cancer cells
Abstract
No abstracts available.
Signal Transduction and Targeted Therapy (Sep 2022)